JP2016540506A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016540506A5 JP2016540506A5 JP2016533639A JP2016533639A JP2016540506A5 JP 2016540506 A5 JP2016540506 A5 JP 2016540506A5 JP 2016533639 A JP2016533639 A JP 2016533639A JP 2016533639 A JP2016533639 A JP 2016533639A JP 2016540506 A5 JP2016540506 A5 JP 2016540506A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- peptide
- protein
- nucleic acid
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101100340759 Homo sapiens C17orf99 gene Proteins 0.000 claims 23
- 102100039063 Protein IL-40 Human genes 0.000 claims 20
- 201000010099 disease Diseases 0.000 claims 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims 13
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 102000004169 proteins and genes Human genes 0.000 claims 13
- 150000007523 nucleic acids Chemical class 0.000 claims 10
- 108020004707 nucleic acids Proteins 0.000 claims 9
- 102000039446 nucleic acids Human genes 0.000 claims 9
- 206010025323 Lymphomas Diseases 0.000 claims 6
- 210000003719 b-lymphocyte Anatomy 0.000 claims 6
- 208000023275 Autoimmune disease Diseases 0.000 claims 4
- 208000007924 IgA Deficiency Diseases 0.000 claims 3
- 208000029462 Immunodeficiency disease Diseases 0.000 claims 3
- 201000004681 Psoriasis Diseases 0.000 claims 3
- 206010039915 Selective IgA immunodeficiency Diseases 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 239000002299 complementary DNA Substances 0.000 claims 3
- 238000003745 diagnosis Methods 0.000 claims 3
- 230000007813 immunodeficiency Effects 0.000 claims 3
- 201000007156 immunoglobulin alpha deficiency Diseases 0.000 claims 3
- 208000032839 leukemia Diseases 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 3
- 208000029138 selective IgA deficiency disease Diseases 0.000 claims 3
- 208000011580 syndromic disease Diseases 0.000 claims 3
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 3
- 239000000556 agonist Substances 0.000 claims 2
- 101001033274 Homo sapiens Protein IL-40 Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361906855P | 2013-11-20 | 2013-11-20 | |
| US61/906,855 | 2013-11-20 | ||
| PCT/US2014/066712 WO2015077506A2 (en) | 2013-11-20 | 2014-11-20 | Identification of a novel b cell cytokine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016540506A JP2016540506A (ja) | 2016-12-28 |
| JP2016540506A5 true JP2016540506A5 (enExample) | 2018-09-06 |
Family
ID=53180393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533639A Pending JP2016540506A (ja) | 2013-11-20 | 2014-11-20 | 新規ｂ細胞サイトカインの同定 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20160297860A1 (enExample) |
| EP (1) | EP3071232A4 (enExample) |
| JP (1) | JP2016540506A (enExample) |
| CN (1) | CN105764527A (enExample) |
| AU (1) | AU2014352891B2 (enExample) |
| CA (1) | CA2929313A1 (enExample) |
| MX (1) | MX2016006586A (enExample) |
| WO (1) | WO2015077506A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3352795B1 (en) * | 2015-09-21 | 2020-08-12 | The Regents of The University of California | Compositions and methods for target nucleic acid modification |
| EP3921649A2 (en) * | 2019-02-08 | 2021-12-15 | Biolegend, Inc. | Uses of il-40 and methods for detecting il-40 activity |
| CN114231611A (zh) * | 2021-12-07 | 2022-03-25 | 中南大学湘雅二医院 | 干扰素诱导基因ifit3对b淋巴细胞活化及分化影响的研究方法 |
| CN118294671B (zh) * | 2024-04-01 | 2025-01-14 | 东南大学 | 白介素40作为生物标志物在脓毒症诊断中的应用 |
| CN119309889B (zh) * | 2024-12-13 | 2025-03-07 | 天津医科大学总医院空港医院 | 一种在eb病毒感染状态下的胸腺增生组织中免疫状态的检测方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030083461A1 (en) * | 1997-06-16 | 2003-05-01 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
| US20080039413A1 (en) * | 2003-10-21 | 2008-02-14 | Morris David W | Novel compositions and methods in cancer |
| EP2358392B1 (en) * | 2008-11-12 | 2019-01-09 | MedImmune, LLC | Antibody formulation |
| WO2011013753A1 (ja) * | 2009-07-29 | 2011-02-03 | シスメックス株式会社 | ヒトil-17産生ヘルパーt細胞検出用マーカーおよび試薬、並びにヒトil-17産生ヘルパーt細胞の検出方法 |
| WO2012118622A1 (en) * | 2011-02-19 | 2012-09-07 | Baylor Research Institute | Diagnostic and therapeutic uses for b cell maturation antigen |
| EP2535714A1 (en) * | 2011-06-16 | 2012-12-19 | Istituto Nazionale Di Genetica Molecolare-INGM | Biomarkers for autoimmune liver diseases and uses thereof |
| US9540657B2 (en) * | 2012-05-25 | 2017-01-10 | California Institute Of Technology | Expression of secreted and cell-surface polypeptides |
-
2014
- 2014-11-20 AU AU2014352891A patent/AU2014352891B2/en not_active Expired - Fee Related
- 2014-11-20 CN CN201480063597.2A patent/CN105764527A/zh active Pending
- 2014-11-20 EP EP14864834.8A patent/EP3071232A4/en not_active Withdrawn
- 2014-11-20 WO PCT/US2014/066712 patent/WO2015077506A2/en not_active Ceased
- 2014-11-20 CA CA2929313A patent/CA2929313A1/en not_active Abandoned
- 2014-11-20 JP JP2016533639A patent/JP2016540506A/ja active Pending
- 2014-11-20 MX MX2016006586A patent/MX2016006586A/es unknown
- 2014-11-20 US US15/036,207 patent/US20160297860A1/en not_active Abandoned
-
2019
- 2019-11-21 US US16/690,395 patent/US20200087368A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Balu et al. | A novel human IgA monoclonal antibody protects against tuberculosis | |
| JP2016540506A5 (enExample) | ||
| JP2017531427A5 (enExample) | ||
| CY1124997T1 (el) | Καινοτομοι υποδοχεις τ-κυτταρων και ανοσοθεραπεια με την χρηση των ιδιων | |
| JP2018172439A5 (enExample) | ||
| FI3683235T3 (fi) | Anti-IL-33-vasta-aineita ja niiden käyttöjä | |
| HRP20241228T1 (hr) | T stanični receptori i imunološka terapija uporabom istih protiv pram pozitivnih karcinoma | |
| JP2017527272A5 (enExample) | ||
| JP2014039548A5 (enExample) | ||
| JP2020517287A5 (enExample) | ||
| JP2019521643A5 (enExample) | ||
| JP2014239695A5 (enExample) | ||
| CN115103852A (zh) | Prame tcr受体和其用途 | |
| HRP20151227T1 (hr) | Sastavi i postupci uporabe za terapeutska protutijela | |
| AR095432A1 (es) | Proteínas de unión a antígeno | |
| JP2016053091A5 (enExample) | ||
| Kuchař et al. | Human interleukin‐23 receptor antagonists derived from an albumin‐binding domain scaffold inhibit IL‐23‐dependent ex vivo expansion of IL‐17‐producing T‐cells | |
| WO2013095738A3 (en) | Monoclonal antibodies with altered affinities for human fcyri, fcyrllla, and c1q proteins | |
| CN112105373B (zh) | 治疗b型肝炎病毒感染的方法 | |
| JP2007535912A5 (enExample) | ||
| CN111094333A (zh) | 异源二聚化的Ig结构域 | |
| Liu et al. | Rational design of CXCR4 specific antibodies with elongated CDRs | |
| JP2018507254A5 (enExample) | ||
| HRP20230605T1 (hr) | Protutijela protiv interferona beta i njihova upotreba | |
| JP2018518940A5 (enExample) |